| P50 | author | April Coan | Q40577753 |
| | Sheena Mukkada | Q88962055 |
| P2093 | author name string | Li Tang | |
| | Miguela A Caniza | |
| | Mae Dolendo | |
| | Cristel Kate Smith | |
| | Delta Aguilar | |
| P2860 | cites work | Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge | Q26797524 |
| | Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation | Q34427584 |
| | Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes | Q36907218 |
| | Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America | Q37220711 |
| | Etiology and clinical course of febrile neutropenia in children with cancer | Q37344556 |
| | SIOP PODC: Recommendations for supportive care of children with cancer in a low-income setting | Q38410073 |
| | Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries | Q38592904 |
| | Evaluation of risk prediction criteria for episodes of febrile neutropenia in children with cancer | Q39597085 |
| | Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study | Q39891473 |
| | Using care bundles to reduce in-hospital mortality: quantitative survey | Q39926694 |
| | Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation | Q40274081 |
| | Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes | Q40436898 |
| | A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. | Q40468203 |
| | Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens | Q40496949 |
| | Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia | Q40575826 |
| | Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever | Q40599720 |
| | A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can | Q40644351 |
| | Predicting the risk of bacteremia in childen with fever and neutropenia | Q40671852 |
| | Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit | Q47735874 |
| | Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. | Q51617424 |
| | Treatment-related mortality in children with acute lymphoblastic leukemia in Central America | Q59305549 |
| | Clinical practice guidelines for children with cancer presenting with fever to the emergency room | Q83648111 |
| P433 | issue | 2 | |
| P577 | publication date | 2017-09-12 | |
| P1433 | published in | Pediatric Blood & Cancer | Q15754342 |
| P1476 | title | Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting | |
| P478 | volume | 65 | |